Exhibit (c)(2) PROJECT HEDWIG Preliminary Reference Materials Requested by Special Committee January 25, 2018

Hedwig – Illustrative Ownership Summary Current Holdings(2) Investor Information WAC(1) Investor Name Style Report / Position Date (mm) (%) Source: FactSet, Public filings 1 1. 2. 3. Weighted average cost base (“WAC”) estimated based on quarterly position changes and average prices since 31-Dec-99. Total share count and ownership percentages are based off of basic common share count of 12.9mm as of 03-Nov-2017, per Hedwig Q3-2017 10-Q. Includes 2.1mm shares owned by institutions outside of the top institutions listed on this slide. PROJECT HEDWIG Top 15 Non-Privet Institutions Royce & Associates Growth 30-Sep-17 $11.46 Dimensional Fund Advisors Growth 30-Sep-17 14.36 BlackRock Fund Advisors Index 30-Sep-17 12.10 Wellington Management Co. Growth 30-Sep-17 11.23 Franklin Advisory Services Growth 30-Sep-17 10.08 The Vanguard Group Index 30-Sep-17 10.44 First Wilshire Securities Management Value 30-Sep-17 11.31 Pacific Ridge Capital Partners Growth 30-Sep-17 11.94 Kennedy Capital Management Growth 30-Sep-17 13.43 Foundry Partners Growth 30-Sep-17 11.59 Renaissance Technologies Growth 30-Sep-17 11.34 Grace & White Value 30-Sep-17 11.35 Bridgeway Capital Management Value 30-Sep-17 11.23 John G. Ullman & Associates Yield 30-Sep-17 11.45 SSgA Funds Management Index 30-Sep-17 10.93 1.1 8.6% 1.1 8.4% 0.8 6.2% 0.6 4.9% 0.6 4.3% 0.4 3.3% 0.3 2.6% 0.3 2.4% 0.3 2.3% 0.3 2.2% 0.3 2.1% 0.3 1.9% 0.2 1.8% 0.2 1.4% 0.2 1.2% Top 15 Non-Privet Institutions $11.86 6.9 53.6% Privet Value 31-Oct-17 $11.17 1.4 10.6% Summary Strategic & Insider Privet Non-Privet Institutional Holders(3) Unidentified Institutional & Retail 0.3 2.7% 1.4 10.6% 9.1 70.1% 2.2 16.6% Total(2) 12.9 100.0%

Hedwig – Turn of Float Analysis SINGLE TURN OF HEDWIG FLOAT ANALYSIS – BASED ON OUTSTANDING FLOAT OF 11.2 MILLION SHARES (DECEMBER 9, 2016 – JANUARY 25, 2018)(1) Current Share Price: US$ 18.53 8% 6% 0% Source: FactSet, Public filings Note: Analysis as of 25-Jan-18. 1. Outstanding float calculated based on common share count of 11.2mm as of 03-Nov-2017 (per Hedwig Q3-2017 10-Q), less 0.3mm of insider holdings, less 1.4mm of Privet holdings. 2 PROJECT HEDWIG 20% 4% 1% 18% 12% 10% 4% 7% 6% 3% 2%

Negative One-Day Premium Transactions Stock Reaction One Day After Ann. Stock Consider-ation Ann. Date Target Company Unaffected Share Price 30-Day VWAP 90-Day VWAP 180-Day VWAP Financial Strategic Going Private Status Acquirer Company Industry 1-Day 13E-3 Buyer Buyer Dec-17 Kindred Healthcare, Inc. Pending Humana, Inc.; TPG Capital LLC; Hospital/Nursing Management (5.3%) 5.8% 13.6% 24.9% 5.1% 0.5% n.a. No No Yes Yes Dec-17 Fairmount Santrol Holdings, Pending Unimin Corp. Construction Materials (84.9%) (84.9%) (84.1%) (81.0%) (82.7%) (0.4%) n.a. No No Yes Yes Oct-17 Inventure Foods, Inc. Complete UTZ Quality Foods LLC Food: Specialty/Candy (10.3%) (10.3%) (14.7%) (0.7%) (6.4%) 0.3% n.a. No No Yes Yes Aug-17 TerraVia Holdings, Inc. Complete Corbion NV Chemicals: Specialty (3.8%) (3.8%) (18.2%) (47.0%) (74.3%) 14.7% n.a. No No Yes No Jul-17 Western Refining Logistics LP Complete Tesoro Logistics LP Oil & Gas Pipelines (2.2%) (2.2%) (1.3%) 0.2% 6.5% (1.2%) 100.0% No No Yes No Jul-17 Rocket Fuel, Inc. Complete Vector Capital Management LP; Information Technology Services (3.3%) (3.3%) (7.3%) (30.4%) (11.5%) (2.2%) n.a. No No Yes Yes Jun-17 Universal Stainless & AlloyPending Synalloy Corp. Steel (4.9%) (4.9%) 1.1% 9.9% 22.6% (0.5%) 74.9% No No Yes No May-17 Straight Path Communications, Pending Verizon Communications, Inc. Specialty Telecommunications (17.8%) 404.0% 64.1% 203.8% 323.1% 0.9% 100.0% No No Yes No Feb-17 DigitalGlobe, Inc. Complete MacDonald, Dettwiler & Associates Specialty Telecommunications (0.1%) 18.0% 14.7% 15.8% 25.4% 0.8% 48.5% No No Yes No Jan-17 Midcoast Energy Partners LP Complete Enbridge Energy Co., Inc. Gas Distributors (8.6%) (8.6%) 7.4% 5.1% 1.1% --n.a. Yes No Yes Yes Dec-16 Tangoe, Inc. Complete Marlin Management Co. LLC; Packaged Software (21.0%) (21.0%) (19.8%) (22.9%) (22.0%) (4.4%) n.a. No No Yes Yes Nov-16 EarthLink Holdings Corp. Complete Windstream Holdings, Inc. Internet Software/Services (4.8%) 13.0% (2.1%) (6.7%) (4.3%) (5.9%) 100.0% No No Yes No Nov-15 Breeze-Eastern LLC Complete TransDigm Group, Inc. Aerospace & Defense (6.6%) (6.6%) 7.2% 30.8% 51.5% 0.8% n.a. No No Yes No Jun-15 Martha Stewart Living Complete Sequential Brands Group, Inc. /Old/ Publishing: Books/Magazines (11.9%) 21.0% 17.1% 11.7% 25.9% 0.7% 50.5% No No Yes No Jun-15 The Ryland Group, Inc. Complete Standard Pacific Corp. Homebuilding (0.4%) (0.4%) 1.4% (4.5%) 4.9% 5.2% 100.0% No No Yes No Apr-15 Baltic Trading Ltd. Complete Genco Shipping & Trading Ltd. Marine Shipping (1.3%) (1.3%) 5.9% (17.1%) (50.9%) 3.0% 100.0% No No Yes No Mar-15 Aruba Networks, Inc. Complete Hewlett-Packard Co. Computer Peripherals (0.6%) 34.4% 37.6% 30.2% 28.6% (1.0%) n.a. No No Yes No Oct-14 Wright Medical Group, Inc. Complete Tornier NV Medical Specialties (23.7%) 28.0% 3.1% 7.3% 13.6% (0.9%) 100.0% No No Yes No Oct-14 Atlas Energy LP Complete Targa Resources Corp. Oil & Gas Pipelines (4.0%) (4.0%) (27.2%) (28.8%) (27.7%) (5.2%) 70.7% No No Yes No Oct-14 Oiltanking Partners LP Complete Enterprise Products Partners LP Wholesale Distributors (1.1%) (1.1%) (2.9%) 2.2% 15.2% (0.3%) 100.0% No No Yes No May-14 PetroLogistics LP Complete Flint Hills Resources LLC Chemicals: Specialty (3.0%) 8.0% (4.4%) (0.1%) 2.3% 0.6% n.a. No No Yes Yes Nov-13 Nielsen Consumer Insights, Complete Nielsen Holdings NV Miscellaneous Commercial Services (1.9%) (1.9%) 3.9% 4.8% 11.1% 0.5% n.a. No No Yes No Oct-13 Consolidated Graphics, Inc. Complete R.R. Donnelley & Sons Co. Commercial Printing/Forms (2.5%) (2.5%) 7.6% 14.0% 31.1% (0.1%) 44.4% No No Yes No Oct-13 International Minerals Corp. Complete Hochschild Mining Plc Precious Metals (7.7%) 20.0% n.a. n.a. n.a. 10.0% n.a. No No Yes No Jul-13 Optimer Pharmaceuticals, Inc. Complete Cubist Pharmaceuticals LLC Pharmaceuticals: Major (20.0%) (20.0%) (25.2%) (25.4%) (13.5%) (5.9%) n.a. No No Yes No Jul-13 Talon Therapeutics, Inc. Complete Spectrum Pharmaceuticals, Inc. Pharmaceuticals: Major (84.9%) (84.9%) (86.1%) (87.8%) (89.3%) n.a. n.a. No No Yes No Aug-12 Comverse Technology, Inc. Complete Verint Systems, Inc. Telecommunications Equipment (35.4%) (35.4%) (33.8%) (38.3%) (40.7%) 1.2% 97.0% No No Yes No May-11 Integral Systems, Inc. Complete Kratos Defense & Security Solutions, Information Technology Services (13.2%) 16.6% (9.9%) (7.9%) 8.6% (0.7%) 60.5% No No Yes No Mar-11 Encore Energy Partners LP Complete Vanguard Natural Resources LLC Oil & Gas Production (5.2%) 4.4% (3.6%) 0.0% 6.6% (1.0%) 100.0% No No Yes No Feb-11 Clinical Data, Inc. Complete Forest Laboratories, Inc. Medical Specialties (11.5%) 19.2% 18.4% 47.8% 71.3% (0.8%) n.a. No No Yes No Feb-11 Frontier Oil Corp. Complete Holly Corp. Oil Refining/Marketing (4.0%) (4.0%) 25.5% 53.6% 76.5% (1.4%) 100.0% No No Yes No Feb-11 Zoran Corp. Complete CSR Plc Semiconductors (1.4%) 40.0% (1.1%) 12.7% 9.2% 15.2% 31.8% No No Yes No Feb-11 Hughes Communications, Inc. Complete EchoStar Corp. Specialty Telecommunications (1.7%) 31.0% 14.0% 47.6% 83.5% 0.3% n.a. No No Yes No Feb-11 Retail Ventures, Inc. Complete DSW, Inc. Department Stores (0.9%) (0.9%) 1.1% 4.2% 29.5% 12.9% 100.0% No No Yes No Dec-10 Compellent Technologies, Inc. Complete Dell, Inc. Computer Peripherals (3.3%) (3.3%) 7.3% 38.6% 68.4% (0.4%) n.a. No No Yes No Jun-10 Valeant Pharmaceuticals Complete Biovail Corp. Pharmaceuticals: Major (6.8%) (6.8%) 182.2% 172.3% 185.2% 8.5% 60.8% No No Yes No Apr-10 Arena Resources, Inc. Complete SandRidge Energy, Inc. Oil & Gas Production (1.8%) 16.8% n.a. n.a. n.a. 7.2% 86.4% No No Yes No Source: FactSet, company filings, news releases Note: No negative premium deal is directly comparable to the transaction under consideration by the Company. Note: Includes all pending / completed deals involving US targets with deal value between $100mm - $5,000mm; excludes companies in FIG and Real Estate industries. 1. VWAP metrics are based on trading days. 3 PROJECT HEDWIG Denotes going private transactions with a financial buyer. Mar-10 infoGROUP, Inc.Complete CCMP Capital AdvisorsData Processing Services(2.0%)22.0%1.9%(0.3%) 11.6%(0.6%)n.a.NoYesNoYes Oct-10 American Commercial Lines, Complete Platinum Equity LLCMarine Shipping(0.9%)(0.9%) 13.9%28.8%38.5%(0.6%)n.a.NoYesNoYes Oct-10 Polymer Group, Inc.Complete The Blackstone Group LPTextiles(19.3%)(19.3%) (14.9%)(9.3%)(4.8%)(2.3%)n.a.NoYesNoYes Feb-11 Emergency Medical Services Complete Clayton Dubilier & Rice LLCOther Transportation(9.4%)18.8%(4.2%)8.5%16.9%0.6%n.a.NoYesNoYes Mar-11 Lawson Software, Inc.Complete Infor Global Solutions EuropeanPackaged Software(2.2%)14.0%10.2%19.1%28.6%6.0%n.a.NoYesNoYes Aug-12 Deltek, Inc.Complete Thoma Bravo LLCPackaged Software(7.2%)24.0%(3.0%)11.8%18.6%--n.a.NoYesNoYes Sep-13 R.G. Barry Corp.Complete The Blackstone Group LP; Mill Road Apparel/Footwear(0.6%)(0.6%) 14.1%17.8%30.0%0.5%n.a.NoYesNoYes Aug-13 Globecomm Systems, Inc.Complete Wasserstein & Co. LPSpecialty Telecommunications(1.7%)21.9%(1.4%)6.3%11.8%(0.2%)n.a.NoYesNoYes Aug-15 Belk, Inc.Complete Sycamore Partners Management LP Department Stores(2.9%)3.5%1.9%1.9%22.2%--n.a.NoYesNoYes May-17 West Corp.Complete Apollo Global Management LLCMiscellaneous Commercial Services (2.5%)17.5%(4.4%)(4.1%)(1.0%)(4.1%)n.a.NoYesNoYes Jul-17 NCI, Inc.Complete H.I.G. Capital LLC (Private Equity) Information Technology Services(5.2%)(5.2%)(0.1%)21.2%35.2%--n.a.NoYesNoYes Deal Information Premium Paid(1) Other Transaction Information

Negative One-Day Premium Transactions (cont’d) Summary of Premiums / Discounts for All Transactions Summary of Premiums / Discounts for Going Private Transactions with Financial Buyer Hedwig Metrics(1) Price 1-Day Price 30-Day VWAP 90-Day VWAP 180-Day VWAP Summary of Other Transaction Information Buyer Classification for the 48 transactions: Financial buyer: Private strategic buyer: Public strategic buyer with all cash consideration: Public strategic buyer with a stock component: 11 7 10 20 Parameters Announcement between 01-Jan-2010 to 12-Jan-2018 Closed or pending transactions Transaction Value: $100mm - $5bn U.S. Public Company Targets Excludes FIG and Real Estate Industries Total Transactions: 921 Number of Transactions with Implied One Day Premiums at a Discount: 48 Percentage of Total Transactions: 5.1% Source: FactSet, company filings, news releases Note: VWAP metrics are based on trading days. 1. Share prices and VWAPs calculated as of 25-Jan-2018. 2. Price before Privet’s 13D amendment describing interest in a transaction. 4 PROJECT HEDWIG Indicative Unaffected Share (2) Share Price Metric $17.75 $18.53 $16.50 $17.80 $16.85 $15.19 Premium / (Discount) to Indicative Price ($17.75) --(4.2%) 7.6% (0.3%) 5.3% 16.9% Unaffected Share Stock Reaction 1-Day Price 30-Day VWAP 90-Day VWAP 180-Day VWAP One Day after Ann. Mean: (4.5%) 8.0% 1.2% 8.5% 17.3% (0.1%) Median: (2.4%) 8.7% (0.0%) 7.4% 17.7% --Unaffected Share Stock Reaction 1-Day Price 30-Day VWAP 90-Day VWAP 180-Day VWAP One Day after Ann. Mean: (9.9%) 9.7% 2.3% 9.6% 19.4% 1.1% Median: (4.0%) (0.7%) 1.1% 5.0% 11.7% --

Disclaimer This presentation, and any supplemental information (written or oral) or other documents provided in connection therewith (collectively, the “materials”), are provided solely for the information of the Board of Directors (the “Board”) of Hardinge Inc. (the “Company”) by BMO in connection with the Board’s consideration of a potential transaction (the “Transaction”) involving the Company. This presentation is incomplete without reference to, and should be considered in conjunction with, any supplemental information provided by and discussions with BMO in connection therewith. Any defined terms used herein shall have the meanings set forth herein, even if such defined terms have been given different meanings elsewhere in the materials. The materials are for discussion purposes only. BMO expressly disclaims any and all liability which may be based on the materials and any errors therein or omissions therefrom. The materials were prepared for specific persons familiar with the business and affairs of the Company for use in a specific context and were not prepared with a view to public disclosure or to conform with any disclosure standards under any state, federal or international securities laws or other laws, rules or regulations, and none of the Board, the Company or BMO takes any responsibility for the use of the materials by persons other than the Board. The materials are provided on a confidential basis solely for the information of the Board and may not be disclosed, summarized, reproduced, disseminated or quoted or otherwise referred to, in whole or in part, without BMO’s express prior written consent. Notwithstanding any other provision herein, the Company (and each employee, representative or other agent of the Company) may disclose to any and all persons without limitation of any kind, the tax treatment and tax structure of any transaction and all materials of any kind (including opinions or other tax analyses, if any) that are provided to the Company relating to such tax treatment and structure. However, any information relating to the tax treatment and tax structure shall remain confidential (and the foregoing sentence shall not apply) to the extent necessary to enable any person to comply with securities laws. For this purpose, the tax treatment of a transaction is the purported or claimed U.S. income or franchise tax treatment of the transaction and the tax structure of a transaction is any fact that may be relevant to understanding the purported or claimed U.S. income or franchise tax treatment of the transaction. If the Company plans to disclose information pursuant to the first sentence of this paragraph, the Company shall inform those to whom it discloses any such information that they may not rely upon such information for any purpose without BMO’s prior written consent. BMO is not an expert on, and nothing contained in the materials should be construed as advice with regard to, legal, accounting, regulatory, insurance, tax or other specialist matters. BMO’s role in reviewing any information is limited solely to performing such a review as it shall deem necessary to support its own advice and analysis and shall not be on behalf of the Board. The materials necessarily are based on financial, economic, market and other conditions as in effect on, and the information available to BMO as of, the date of the materials. Although subsequent developments may affect the contents of the materials, BMO has not undertaken, and is under no obligation, to update, revise or reaffirm the materials, except as may be expressly contemplated by BMO’s engagement letter. The materials are not intended to provide the sole basis for evaluation of the Transaction and do not purport to contain all information that may be required. The materials do not address the underlying business decision of the Company or any other party to proceed with or effect the Transaction, or the relative merits of the Transaction as compared to any alternative business strategies or transactions that might be available for the Company or any other party. The materials do not constitute any opinion, nor do the materials constitute a recommendation to the Board, the Company, any security holder of the Company or any other party as to how to vote or act with respect to any matter relating to the Transaction or otherwise or whether to buy or sell any assets or securities of any company. BMO’s only opinion is the opinion, if any, that is actually delivered to the Board. The materials may not reflect information known to other professionals in other business areas of BMO and its affiliates. The preparation of the materials was a complex process involving quantitative and qualitative judgments and determinations with respect to the financial, comparative and other analytic methods employed and the adaption and application of these methods to the unique facts and circumstances presented and, therefore, is not readily susceptible to partial analysis or summary description. Furthermore, BMO did not attribute any particular weight to any analysis or factor considered by it, but rather made qualitative judgments as to the significance and relevance of each analysis and factor. Each analytical technique has inherent strengths and weaknesses, and the nature of the available information may further affect the value of particular techniques. Accordingly, the analyses contained in the materials must be considered as a whole. Selecting portions of the analyses, analytic methods and factors without considering all analyses and factors could create a misleading or incomplete view. The materials reflect judgments and assumptions with regard to industry performance, general business, economic, regulatory, market and financial conditions and other matters, many of which are beyond the control of the participants in the Transaction. Any estimates of value contained in the materials are not necessarily indicative of actual value or predictive of future results or values, which may be significantly more or less favorable. Any analyses relating to the value of assets, businesses or securities do not purport to be appraisals or to reflect the prices at which any assets, businesses or securities may actually be sold. The materials do not constitute a valuation opinion or credit rating. In preparing the materials, BMO has not conducted any physical inspection or independent appraisal or evaluation of any of the assets, properties or liabilities (contingent or otherwise) of the Company or any other party and has no obligation to evaluate the solvency of the Company or any other party under any law. All budgets, projections, estimates, financial analyses, reports and other information with respect to operations (including estimates of potential cost savings and expenses) reflected in the materials have been prepared by management of the relevant party or are derived from such budgets, projections, estimates, financial analyses, reports and other information or from other sources, which involve numerous and significant subjective determinations made by management of the relevant party and/or which such management has reviewed and found reasonable. The budgets, projections and estimates (including, without limitation, estimates of potential cost savings and synergies) contained in the materials may or may not be achieved and differences between projected results and those actually achieved may be material. BMO has relied upon representations made by management of the Company that such budgets, projections and estimates have been reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of such management (or, with respect to information obtained from public sources, represent reasonable estimates), and BMO expresses no opinion with respect to such budgets, projections or estimates or the assumptions on which they are based. The scope of the financial analysis contained herein is based on discussions with the Company (including, without limitation, regarding the methodologies to be utilized), and BMO does not make any representation, express or implied, as to the sufficiency or adequacy of such financial analysis or the scope thereof for any particular purpose. BMO has assumed and relied upon the accuracy and completeness of the financial and other information provided to, discussed with or reviewed by it without (and without assuming responsibility for) independent verification of such information, makes no representation or warranty (express or implied) in respect of the accuracy or completeness of such information and has further relied upon the assurances of the Company that it is not aware of any facts or circumstances that would make such information inaccurate or misleading. In addition, BMO has relied upon and assumed, without independent verification, that there has been no change in the business, assets, liabilities, financial condition, results of operations, cash flows or prospects of the Company, the division of the Company being sold, or any other participant in the Transaction since the respective dates of the most recent financial statements and other information, financial or otherwise, provided to BMO that would be material to its analyses, and that the final forms of any draft documents reviewed by BMO will not differ in any material respect from such draft documents. The materials are not an offer to sell or a solicitation of an indication of interest to purchase any security, option, commodity, future, loan or currency. The materials do not constitute a commitment by BMO or any of its affiliates to underwrite, subscribe for or place any securities, to extend or arrange credit, or to provide any other services. In the ordinary course of business, certain of BMO’s affiliates and employees, as well as investment funds in which they may have financial interests or with which they may co-invest, may acquire, hold or sell, long or short positions, or trade or otherwise effect transactions, in debt, equity, and other securities and financial instruments (including loans and other obligations) of, or investments in, one or more parties that may be involved in the Transaction and their respective affiliates or any currency or commodity that may be involved in the Transaction. BMO provides mergers and acquisitions, restructuring and other advisory and consulting services to clients. BMO’s personnel may make statements or provide advice that is contrary to information contained in the materials. BMO’s or its affiliates’ proprietary interests may conflict with the Company’s interests. BMO may have advised, may seek to advise and may in the future advise one or more participants in the Transaction and/or other companies mentioned in the materials. All values in this document are in US$ unless otherwise specified 5 PROJECT HEDWIG